Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jul;142(1):45-51.
doi: 10.1111/j.1365-2141.2008.07156.x. Epub 2008 May 8.

Hairy cell leukaemia: a heterogeneous disease?

Affiliations

Hairy cell leukaemia: a heterogeneous disease?

Graça M Dores et al. Br J Haematol. 2008 Jul.

Abstract

The US National Cancer Institute's Surveillance, Epidemiology and End Results program was used to develop aetiological clues for hairy cell leukaemia (HCL). Descriptive techniques (age-adjusted incidence trends, age-specific incidence rates (IR), and age distributions-at-diagnosis) were supplemented with mathematical models (two-component mixture, generalized linear regression, and age-period-cohort). There were 2856 cases of HCL diagnosed during 1978-2004 (IR 0.32/100,000 person-years). IRs were nearly 4-fold greater among men than women and more than 3-fold higher for Whites than Blacks. Temporal trends were stable over time. Age-specific IRs increased rapidly until approximately 40 years then rose at a slower pace. The age-specific IR curves reflected bimodal early- and late-onset age distributions-at-diagnosis (or density plots), with some variation by gender. Among both men and women, a two-component mixture model fitted the data better than a single density or cancer population. Age-period-cohort models confirmed statistically significant age-related effects after full adjustment for temporal trends (calendar-period and birth-cohort effects). In summary, age incidence patterns (rates and bimodal densities) suggested that HCL is a heterogeneous disease, consisting of at least two underlying subgroups and/or cancer populations by age-at-onset. Distinct early- and late-onset HCL populations may reflect different age-related causal pathways, risk factor profiles, and/or stem cells of origin.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Age-adjusted temporal trends of HCL diagnosed in SEER-17 (1978–2004) according to gender, with P value for trend interaction by gender.
Fig 2
Fig 2
Age-specific incidence and age-distribution of HCL diagnosed in SEER-17 according to gender (1978–2004). (A) Age-specific IRs among males and females, with P value for trend interaction by gender. Age density plots among (B) males and (C) females (95% confidence limits were applied with bootstrap re-sampling techniques).
Fig 3
Fig 3
Age-period-cohort model of HCL diagnosed in SEER-17 (1980–2004). (A) Age effects as rates for the reference period. (B) Period effects as relative risks for the reference period. (C) Cohort effects constrained to be 0 on average with 0 slope. In a sensitivity analysis, age effects were robust for all constraints or parameterizations. Dashed vertical line – reference line. CI, confidence interval.

References

    1. Akaike H. Information theory and an extension of the maximum likelihood principle. In: Petrov BN, Csaki F, editors. International Symposium on Information Theory. 1973. pp. 267–281.
    1. Akademiai Kiado Budapest, Anderson WF, Chu KC, Chatterjee N, Brawley O, Brinton LA. Tumor variants by hormone receptor expression in white patients with node-negative breast cancer from the surveillance, epidemiology, and end results database. Journal of Clinical Oncology. 2001;19:18–27. - PubMed
    1. Anderson WF, Pfeiffer RM, Dores GM, Sherman ME. Comparison of age distribution patterns for different histopathologic types of breast carcinoma. Cancer Epidemiology, Biomarkers and Prevention. 2006;15:1899–1905. - PubMed
    1. Anderson WF, Chen BE, Brinton LA, Devesa SS. Qualitative age interactions (or effect modification) suggest different cancer pathways for early-onset and late-onset breast cancers. Cancer Causes and Control. 2007a;18:1187–1198. - PubMed
    1. Anderson WF, Matsuno RK, Sherman ME, Lissowska J, Gail MH, Brinton LA, Yang XR, Peplonska B, Chen BE, Rosenberg PS, Chatterjee N, Szeszenia-Dabrowska N, Bardin-Mikolajczak A, Zatonski W, Devesa SS, Garcia-Closas M. Estimating age-specific breast cancer risks: a descriptive tool to identify age interactions. Cancer Causes and Control. 2007b;18:439–447. - PubMed

Publication types